[EN] PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS<br/>[FR] PYRAZOLOPYRIMIDINES EN TANT QU'AGENTS THERAPEUTIQUES
申请人:BASF AG
公开号:WO2001019829A2
公开(公告)日:2001-03-22
The present invention provides compounds of Formula (I), including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, R3 are defined as described herein and their use as protein Kinase inhibitors.
本发明提供了式(I)的化合物,包括其药学上可接受的盐和/或前药,其中G、Ra、R2、R3的定义如本文所述,并且它们作为蛋白激酶抑制剂的用途。